Peptide Cycle Guide

Cycling refers to the practice of using a peptide for a defined period ("on" phase) followed by a break ("off" phase) before resuming use. There are several important reasons why cycling is a cornerstone of responsible peptide research:

• Receptor Desensitization: Continuous stimulation of a receptor can lead to downregulation — the body reduces receptor expression or sensitivity as an adaptive response. This means the same dose produces progressively weaker effects over time.
• Homeostatic Adaptation: The body's endocrine and metabolic systems seek equilibrium. Prolonged exogenous peptide use can suppress natural production of related hormones or signaling molecules.
• Safety Margins: Periodic breaks allow organ systems to recover and reduce the cumulative exposure to any compound, particularly those with growth-promoting properties.
• Cost Efficiency: Cycling prevents wasting peptides during periods of diminished response due to desensitization.

Not all peptides require the same cycling approach. Some compounds like BPC-157 show minimal desensitization in animal models, while growth hormone secretagogues may require more structured on/off protocols to maintain efficacy.

The optimal cycle length and structure varies by peptide category. Here are the most commonly referenced protocols in the research community:

These protocols are derived from published research, anecdotal research community reports, and pharmacological principles. They are not clinical recommendations.

The "on" phase is when the peptide is actively being administered. Key considerations for optimizing this phase:

• Start Low, Titrate Up: Begin at the lower end of the dosage range for the first 3–7 days. This allows you to assess tolerance and identify any adverse reactions before reaching the full research dose.
• Maintain Consistency: Administer at the same time(s) each day. Many peptides, particularly growth hormone secretagogues, are most effective when timed around natural hormonal rhythms (e.g., evening dosing to coincide with natural GH pulses during sleep).
• Track Everything: Maintain a detailed research log documenting doses, timing, injection sites, and any observations. Objective measurements (weight, body composition, sleep quality scores) are more valuable than subjective impressions.
• Watch for Desensitization: If you notice diminishing effects mid-cycle, this may indicate receptor desensitization. Some researchers implement "mini breaks" — 2 days off per week — to mitigate this.

The 5/2 Protocol: A popular approach for growth hormone secretagogues is to administer for 5 consecutive days followed by 2 days off each week. This micro-cycling approach helps maintain receptor sensitivity throughout a longer overall cycle.

The off phase is not simply "doing nothing" — it serves critical biological purposes:

• Receptor Upregulation: During the break, receptors that may have been downregulated during the on phase return to baseline sensitivity, ensuring the next cycle will be effective.
• Endogenous Recovery: If the peptide was supplementing or stimulating a natural hormone (e.g., growth hormone), the off phase allows the body's own production pathways to normalize.
• Assessment Period: The off phase is the best time to evaluate what changes persist without the peptide. Effects that remain during the off phase may represent genuine structural or physiological adaptations rather than just acute drug effects.

Off Phase Best Practices:

• Maintain your training, nutrition, and sleep protocols — don't change multiple variables at once
• Continue logging observations to compare with on-phase data
• Use the break to get bloodwork done (hormonal panels, metabolic markers) to assess baseline levels
• Resist the urge to cut the off phase short — full receptor recovery takes time

Post-cycle therapy — a concept borrowed from anabolic steroid use — refers to interventions during the off phase designed to help the body restore natural hormone production. The relevance of PCT varies significantly by peptide type:

Peptides That Generally Do NOT Require PCT:

• BPC-157 — does not significantly suppress any hormonal axis
• TB-500 — no known hormonal suppression
• GHK-Cu — works through copper peptide signaling, not hormonal pathways
• Semaglutide/Tirzepatide — GLP-1 agonists don't affect the HPG axis

Peptides Where PCT May Be Relevant:

• Growth Hormone Secretagogues: Prolonged use of Ipamorelin, CJC-1295, or similar GHRPs may temporarily suppress natural GH pulsatility. The body typically recovers within 2–4 weeks without intervention, but some researchers use a tapering approach rather than abrupt cessation.
• IGF-1 LR3: Extended use can alter the GH/IGF-1 axis. A clean break with monitoring of IGF-1 blood levels is recommended before resuming.

General PCT Strategies for Peptides:

• Gradual dose tapering over the final 5–7 days rather than abrupt cessation
• Prioritizing sleep quality (7–9 hours) to support natural GH recovery
• Optimizing nutrition with adequate protein intake and micronutrient support (zinc, magnesium, vitamin D)
• Bloodwork to verify hormonal recovery before initiating the next cycle

Unlike anabolic steroids, most peptides do not cause significant hypothalamic-pituitary-gonadal (HPG) axis suppression, making aggressive PCT protocols (SERMs, AIs) unnecessary in the vast majority of peptide cycles.

Stacking refers to running two or more peptides simultaneously during a cycle. Popular stacking combinations include:

• BPC-157 + TB-500: The classic recovery stack. Complementary mechanisms — BPC-157 promotes local healing factors while TB-500 provides systemic anti-inflammatory and tissue repair signaling.
• Ipamorelin + CJC-1295 (no DAC): The standard GH optimization stack. CJC-1295 provides sustained GHRH stimulation while Ipamorelin provides targeted GH release with minimal cortisol/prolactin effects.
• BPC-157 + GHK-Cu: A recovery and regeneration stack with good synergy — BPC-157 handles connective tissue repair while GHK-Cu supports skin, collagen, and cellular rejuvenation.

Stacking Rules:

• Never introduce more than one new peptide at a time. Run a solo cycle of each compound first to understand individual responses.
• Align cycle lengths — if stacking two peptides with different recommended cycle durations, use the shorter recommendation as your guide.
• Monitor for synergistic side effects. Combining two growth-promoting peptides increases both benefits and risks.
• Keep detailed records of which peptides were running during each cycle for accurate assessment.

Reliable sourcing is especially important when running structured cycles, as consistency in peptide quality directly affects the validity of your research observations. Look for:

• Batch-to-batch consistency verified by COAs
• HPLC purity ≥98% from independent testing labs
• Proper lyophilization for maximum shelf stability
• Adequate inventory to supply a full cycle without switching suppliers mid-protocol

Ascension Peptides provides research-grade peptides with consistent batch quality, comprehensive third-party testing, and fast shipping to ensure your research cycles proceed without interruption. All products are for research and laboratory use only.

Disclaimer: This guide is for educational and research purposes only. The cycling protocols described are not medical advice and are not approved by the FDA. Consult a qualified healthcare provider before beginning any peptide protocol. Never use research chemicals for self-administration.